000 | 01924 a2200505 4500 | ||
---|---|---|---|
005 | 20250513220141.0 | ||
264 | 0 | _c20000920 | |
008 | 200009s 0 0 eng d | ||
022 | _a0270-4137 | ||
024 | 7 |
_a10.1002/1097-0045(20000915)45:1<51::aid-pros6>3.0.co;2-9 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _adel Vecchio, M T | |
245 | 0 | 0 |
_aMacrophage migration inhibitory factor in prostatic adenocarcinoma: correlation with tumor grading and combination endocrine treatment-related changes. _h[electronic resource] |
260 |
_bThe Prostate _cSep 2000 |
||
300 |
_a51-7 p. _bdigital |
||
500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't | ||
650 | 0 | 4 |
_aAdenocarcinoma _xdrug therapy |
650 | 0 | 4 | _aAged |
650 | 0 | 4 |
_aAndrogen Antagonists _xadministration & dosage |
650 | 0 | 4 |
_aAndrogens _xphysiology |
650 | 0 | 4 |
_aAntineoplastic Agents, Hormonal _xadministration & dosage |
650 | 0 | 4 |
_aAntineoplastic Combined Chemotherapy Protocols _xtherapeutic use |
650 | 0 | 4 | _aBiopsy, Needle |
650 | 0 | 4 |
_aCell Differentiation _xdrug effects |
650 | 0 | 4 |
_aFlutamide _xadministration & dosage |
650 | 0 | 4 |
_aGonadotropin-Releasing Hormone _xagonists |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 | _aImmunohistochemistry |
650 | 0 | 4 |
_aMacrophage Migration-Inhibitory Factors _xbiosynthesis |
650 | 0 | 4 | _aMale |
650 | 0 | 4 | _aMiddle Aged |
650 | 0 | 4 | _aNeoadjuvant Therapy |
650 | 0 | 4 | _aPrognosis |
650 | 0 | 4 |
_aProstate _xmetabolism |
650 | 0 | 4 |
_aProstatic Intraepithelial Neoplasia _xdrug therapy |
650 | 0 | 4 |
_aProstatic Neoplasms _xdrug therapy |
700 | 1 | _aTripodi, S A | |
700 | 1 | _aArcuri, F | |
700 | 1 | _aPergola, L | |
700 | 1 | _aHako, L | |
700 | 1 | _aVatti, R | |
700 | 1 | _aCintorino, M | |
773 | 0 |
_tThe Prostate _gvol. 45 _gno. 1 _gp. 51-7 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1002/1097-0045(20000915)45:1<51::aid-pros6>3.0.co;2-9 _zAvailable from publisher's website |
999 |
_c10908390 _d10908390 |